Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Cloud Architect page is loaded# Cloud Architectlocations: Switzerland - Baseltime type: Full timeposted on: Posted Todayjob requisition id: # JOB DESCRIPTION: Abbott is a global healthcare leader that helps people live more fully at all stages